• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

1-(3-Methoxyphenyl)Piperazine Hydrochloride: A Comprehensive Overview

1-(3-Methoxyphenyl)piperazine hydrochloride (CAS No. 16015-70-6) is a versatile compound with significant applications in the fields of pharmaceuticals, neuroscience, and chemical research. This compound, also known as MOPP, is a derivative of piperazine and features a methoxyphenyl group, which imparts unique pharmacological properties. In this detailed overview, we will explore the chemical structure, synthesis, pharmacological effects, and potential therapeutic applications of 1-(3-Methoxyphenyl)piperazine hydrochloride.

Chemical Structure and Synthesis:

The molecular formula of 1-(3-Methoxyphenyl)piperazine hydrochloride is C₁₂H₁₇N₂O·HCl, with a molecular weight of approximately 239.73 g/mol. The compound consists of a piperazine ring attached to a 3-methoxyphenyl group. The methoxy group at the para position of the phenyl ring enhances the lipophilicity and stability of the molecule, contributing to its biological activity.

The synthesis of 1-(3-Methoxyphenyl)piperazine hydrochloride can be achieved through various methods. One common approach involves the reaction of 3-methoxybenzaldehyde with piperazine in the presence of an acid catalyst, followed by hydrochloric acid treatment to form the hydrochloride salt. This method is widely used due to its simplicity and high yield.

Pharmacological Properties:

1-(3-Methoxyphenyl)piperazine hydrochloride exhibits a range of pharmacological effects, primarily due to its interaction with serotonin receptors. It acts as a serotonin receptor agonist, particularly at the 5-HT_1A, 5-HT_2A, and 5-HT_2C receptors. This property makes it a valuable tool in studying serotonin-mediated pathways and their role in various neurological disorders.

In addition to its serotonergic activity, MOPP also interacts with dopamine receptors, particularly D₂. This dual action on serotonin and dopamine receptors suggests potential applications in treating conditions such as depression, anxiety, and schizophrenia. Recent studies have shown that MOPP-like compounds can modulate neurotransmitter systems in ways that may offer therapeutic benefits without the side effects associated with traditional antidepressants and antipsychotics.

Clinical Applications:

The potential therapeutic applications of 1-(3-Methoxyphenyl)piperazine hydrochloride are an active area of research. Preclinical studies have demonstrated its efficacy in animal models of depression and anxiety. For instance, administration of MOPP has been shown to reduce depressive-like behaviors in rodents through its modulation of serotonin and dopamine systems.

In the context of schizophrenia, MOPP-like compounds have been investigated for their ability to improve cognitive function and reduce positive symptoms. Clinical trials are currently underway to evaluate the safety and efficacy of these compounds in human patients. Preliminary results are promising, suggesting that MOPP-based therapies may offer a novel approach to treating psychiatric disorders.

Toxicology and Safety: strong>

The safety profile of 1-(3-Methoxyphenyl)piperazine hydrochloride strong> is an important consideration for its potential therapeutic use. Preclinical toxicology studies have generally shown that it is well-tolerated at therapeutic doses. However, like many psychoactive compounds, it can produce side effects such as dizziness, nausea, and changes in blood pressure at higher doses.

To ensure safe use in clinical settings, ongoing research is focused on optimizing dosing regimens and identifying patient populations most likely to benefit from treatment with < strong>MOPP strong>. Additionally, efforts are being made to develop analogs with improved safety profiles while retaining the desired pharmacological properties. p > < p >< strong >Conclusion: strong > p > < p >< strong >1-(3-Methoxyphenyl)piperazine hydrochloride strong > (CAS No. 16015-70-6) is a promising compound with diverse applications in pharmaceutical research and development. Its unique chemical structure and pharmacological properties make it a valuable tool for studying neurotransmitter systems and developing new therapies for psychiatric disorders. As research continues to advance our understanding of this compound, it holds significant potential for improving patient outcomes in various clinical settings. p > article > response >

• 16015-71-7(1-(3-Methoxyphenyl)piperazine)
• 53557-93-0(1-(3,5-Dimethoxyphenyl)piperazine)
• 62755-62-8(1-(3-phenoxyphenyl)piperazine)
• 74852-62-3(4-4-(4-Methyloxy-phenyl)-piperazin-1-yl-phenylamine)
• 38212-30-5(1-(4-Methoxyphenyl)piperazine)
• 38869-47-5(1-(4-Methoxyphenyl)piperazine dihydrochloride)
• 58260-71-2(Piperazine,1-(3,4-dimethoxyphenyl)-, hydrochloride (1:2))
• 84145-43-7(1-(4-Methoxyphenyl)piperazine hydrochloride)
• 6968-76-9(1-(3-Methoxyphenyl)piperazine dihydrochloride)
• 16015-72-8(1-(3,4-Dimethoxyphenyl)piperazine hydrochloride)